SmallCapStocks Archives Index | Subscribe | RSS
<< May15, 2005 - RSFF Acquires Five Offices, Now Operates From Twenty Locations May26, 2005 - WIND Reports Strong 1st Quarter >>

Subject: RSFF Provides Oultook - May23, 2005



 

  SmallCapReview News  
  May 23, 2005  
 

The following companies have released news or been in the media since our last update.

Resolve Staffing Discusses Outlook for 2005...(RSFF)

Resolve Staffing, Inc. Opens its 20th Staffing Office...(RSFF)

Generex Biotechnology Immune-Response Strategy to Be Tested for Use Against Cancer...(GNBT)

Generex Biotechnology Corporation Chairman and CEO Provides Insight on Commercial Marketing and Sale of Key Product and Future Growth Of Company in Special Letter to Shareholders...(GNBT)


Resolve Staffing...(RSFF) RSFF has gained 25% since our introduction a week ago.

Press Release: Resolve Staffing Discusses Outlook for 2005

From increasing revenue generation, to the closing of a number of acquisitions and increasing shareholder value, Resolve Staffing is laying the groundwork for a tremendous year of success.

Management has set a new course for success since developing a strategic relationship with ELS Human Resources. Resolve has put together agreements to acquire multiple companies, opened new locations and continues to seek numerous other opportunities. 

To view the Full Press Release please visit http://biz.yahoo.com/pz/050523/78635.html

Press Release: Resolve Staffing, Inc. Opens its 20th Staffing Office

Resolve Staffing has acquired Strategic Management Resources, Inc., located in Erie, PA, bringing the company to total of 9 locations in the Northeast and 20 overall.

To view the Full Press Release please visit http://biz.yahoo.com/bw/050516/165492.html?.v=1

For the Full Profile on RSFF please visit http://www.smallcapreview.com/rsff.htm


Generex Biotechnology...(GNBT)

Press Release: Generex Biotechnology Immune-Response Strategy to Be Tested for Use Against Cancer

Announced today that its wholly owned subsidiary, Antigen Express, has signed an agreement with Dr. Ralph Reisfeld, Ph.D., professor of immunology at The Scripps Research Institute, to test the potency of a modified DNA vaccine for treatment of various forms of cancer.

Scripps, in La Jolla, California, is one of largest private, non-profit research organizations in the U.S.

To view the Full Press Release please visit http://biz.yahoo.com/prnews/050511/nyw059.html?.v=10

Press Release: Generex Biotechnology Corporation Chairman and CEO Provides Insight on Commercial Marketing and Sale of Key Product and Future Growth Of Company in Special Letter to Shareholders

Announced that it has issued a Special Letter to Shareholders in an effort to update existing Generex investors on the current status of the Company, and more importantly, management's perspective on the Company's future growth outlook.

To view the Full Press Release please visit http://biz.yahoo.com/prnews/050510/nytu095.html?.v=7

For the Full Profile on GNBT please visit http://www.smallcapreview.com/gnbt.htm


 

Disclaimer  

SmallCapReview.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. For continuing coverage of RSFF and GNBT please sign up for our free newsletter, SmallCapReview.com News. Information contained in this report was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our web site. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

Copyright SmallCapReview.com. All rights reserved. SmallCapReview.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our web site and individual reports released to the public through this web site, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility. Particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports. In order to be in full compliance with the Securities Act  of 1933, Section 17(b), SmallCapReview.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the SmallCapReview.com web site. SmallCapReview.com has been compensated nine thousand dollars by Resolve Staffing for its efforts in presenting the Resolve Staffing profile on its web site and distributing it to its database of subscribers. SmallCapReview.com has been compensated three thousand dollars by a third party for its efforts in presenting the Generex Biotechnology profile on its web site and distributing it to its database of subscribers. SmallCapReview.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. Information presented on our web site and within our reports contain "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as ???expects??™???, ???will,??? ???anticipates,??? ???estimates, ???believes,??? or that by statements indicating certain actions ???may,??? ???could,??? or ???might??? occur.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com . Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.


 
 








<< May15, 2005 - RSFF Acquires Five Offices, Now Operates From Twenty Locations May26, 2005 - WIND Reports Strong 1st Quarter >>
SmallCapStocks Archives Index | Subscribe | RSS
Google
 
Web http://archives.zinester.com
Archives powered by Zinester's Mailing List Service
Details on SmallCapStocks
Browse for more newsletters at Zinester's Ezine Directory
Managed by Zinester's Mailing List Management